Lumibird SA (LBIRD.PA)
Makes lasers for factories, hospitals, scientists, and military applications.
26.95-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+43.0%
The outlook
Lumibird is trading near the upper end of its 52-week range, comfortably above both its 50- and 200-day moving averages. All three analysts covering the stock rate it a Strong Buy, with an average price target about 18% above the current level. The stock carries a relatively high trailing P/E of 42.1, reflecting elevated investor expectations.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range88% of the way from its 52-week low to high
Price targetAvg target +18% vs current price
Analyst price target
~12-month · 3 analysts31.83average target+18.1% vs now
Now 26.95
Low 30.00High 34.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$594.7M
52-wk high
28.50
52-wk low
15.75
50-day avg
25.50
200-day avg
22.71
Trailing P/E
42.1